{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:48:08Z","timestamp":1787932088852,"version":"build-2784847793"},"reference-count":90,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cranio-Maxillofacial Surgery"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jcms.2024.01.007","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T20:41:00Z","timestamp":1706820060000},"page":"671-691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The effectiveness of autologous platelet concentrates in prevention and treatment of medication-related osteonecrosis of the jaws: A systematic review"],"prefix":"10.1016","volume":"52","author":[{"given":"Sylwia Maria","family":"Nowak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9088-6989","authenticated-orcid":false,"given":"Fraser Lloyd","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3709-5619","authenticated-orcid":false,"given":"Vinod","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3424-5968","authenticated-orcid":false,"given":"Katarzyna","family":"Gurzawska-Comis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jcms.2024.01.007_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.14219\/jada.archive.2007.0294","article-title":"The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors","volume":"138","author":"Adornato","year":"2007","journal-title":"J Am Dent Assoc"},{"issue":"9","key":"10.1016\/j.jcms.2024.01.007_bib2","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jcms.2018.05.046","article-title":"Osteonecrosis of the jaw in patients treated with denosumab: a multicenter case series","volume":"46","author":"Aljohani","year":"2018","journal-title":"J. Cranio-Maxillo-Fac. Surg."},{"issue":"2","key":"10.1016\/j.jcms.2024.01.007_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/odi.12992","article-title":"Surgical treatment of medication-related osteonecrosis of the upper jaw: case series","volume":"25","author":"Aljohani","year":"2019","journal-title":"Oral Dis."},{"issue":"7","key":"10.1016\/j.jcms.2024.01.007_bib4","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00784-016-2004-z","article-title":"Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study","volume":"21","author":"Asaka","year":"2017","journal-title":"Clin Oral Investig"},{"issue":"3","key":"10.1016\/j.jcms.2024.01.007_bib5","first-page":"233","article-title":"The efficacy of platelet-rich plasma in grafted maxillae. A randomised clinical trial","volume":"3","author":"Badr","year":"2010","journal-title":"Eur J Oral Implantol"},{"issue":"7","key":"10.1016\/j.jcms.2024.01.007_bib6","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jcms.2015.04.026","article-title":"Adipose-derived stem cells and platelet-rich plasma for preventive treatment of bisphosphonate-related osteonecrosis of the jaw in a murine model","volume":"43","author":"Barba-Recreo","year":"2015","journal-title":"J. Cranio-Maxillo-Fac. Surg."},{"issue":"7","key":"10.1016\/j.jcms.2024.01.007_bib7","article-title":"Interventions for managing medication\u2010related osteonecrosis of the jaw","author":"Beth-Tasdogan","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.jcms.2024.01.007_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11030682","article-title":"Non-interventional prospective observational study of platelet rich fibrin as a therapy adjunctive in patients with medication-related osteonecrosis of the jaw","volume":"11","author":"Blatt","year":"2022","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.jcms.2024.01.007_bib9","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.ijom.2012.04.020","article-title":"Use of platelet-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw","volume":"41","author":"Bocanegra-P\u00e9rez","year":"2012","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"3","key":"10.1016\/j.jcms.2024.01.007_bib10","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1016\/j.oooo.2018.02.681","article-title":"Osteoradionecrosis, osteomyelitis, and medication-related osteonecrosis of the jaws: comparative histopathological study","volume":"126","author":"Cardoso","year":"2018","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"},{"issue":"4","key":"10.1016\/j.jcms.2024.01.007_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.joms.2013.12.007","article-title":"Management of antiresorptive osteonecrosis of the jaws with primary surgical resection","volume":"72","author":"Carlson","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"1","key":"10.1016\/j.jcms.2024.01.007_bib12","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1038\/s41598-019-44755-6","article-title":"Antimicrobial capacity of leucocyte-and platelet rich fibrin against periodontal pathogens","volume":"9","author":"Castro","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jcms.2024.01.007_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2023.116722","article-title":"Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents - a retrospective study of 240 patients","volume":"170","author":"Coropciuc","year":"2023","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.jcms.2024.01.007_bib14","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.joms.2011.02.078","article-title":"Bisphosphonate-related osteonecrosis of the jaws--an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma","volume":"69","author":"Curi","year":"2011","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jcms.2024.01.007_bib15","doi-asserted-by":"crossref","first-page":"8553","DOI":"10.3390\/app11188553","article-title":"Resective surgery versus debridement in stage 2 medication-related osteonecrosis of the jaw","volume":"11","author":"D'Amato","year":"2021","journal-title":"Appl. Sci."},{"issue":"5","key":"10.1016\/j.jcms.2024.01.007_bib16","first-page":"33","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays","volume":"61","author":"Damm","year":"2013","journal-title":"Gen. Dent."},{"issue":"12","key":"10.1016\/j.jcms.2024.01.007_bib17","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1002\/hed.25944","article-title":"Adjuvant therapies in the management of medication-related osteonecrosis of the jaws: systematic review","volume":"41","author":"de Souza Tolentino","year":"2019","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.jcms.2024.01.007_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/2320206819895836","article-title":"Role of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) in oro-facial tissue regeneration: a narrative review","volume":"11","author":"Deeb","year":"2020","journal-title":"J. Adv. Oral Res."},{"issue":"3","key":"10.1016\/j.jcms.2024.01.007_bib19","first-page":"961","article-title":"Clinical and histopathological studies using fibrin-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw","volume":"55","author":"Dinc\u0103","year":"2014","journal-title":"Rom. J. Morphol. Embryol."},{"issue":"3","key":"10.1016\/j.jcms.2024.01.007_bib20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tibtech.2008.11.009","article-title":"Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)","volume":"27","author":"Dohan Ehrenfest","year":"2009","journal-title":"Trends Biotechnol."},{"issue":"9","key":"10.1016\/j.jcms.2024.01.007_bib21","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin. Proc."},{"issue":"3","key":"10.1016\/j.jcms.2024.01.007_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF00298728","article-title":"Aminoalkylbisphosphonates, potent inhibitors of bone resorption, induce a prolonged stimulation of histamine synthesis and increase macrophages, granulocytes, and osteoclasts in vivo","volume":"52","author":"Endo","year":"1993","journal-title":"Calcif. Tissue Int."},{"issue":"4","key":"10.1016\/j.jcms.2024.01.007_bib23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1902\/jop.2015.150406","article-title":"Effects on bone repair of osteotomy with drills or with erbium, chromium: yttrium-scandium-gallium-garnet laser: histomorphometric and immunohistochemical study","volume":"87","author":"Esteves","year":"2016","journal-title":"J. Periodontol."},{"key":"10.1016\/j.jcms.2024.01.007_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/boneres.2016.36","article-title":"Application of platelet-rich plasma with stem cells in bone and periodontal tissue engineering","volume":"4","author":"Fernandes","year":"2016","journal-title":"Bone Res"},{"issue":"6","key":"10.1016\/j.jcms.2024.01.007_bib25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF02555852","article-title":"Inhibition of bone resorption by bisphosphonates: interactions between bisphosphonates, osteoclasts, and bone","volume":"49","author":"Flanagan","year":"1991","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.jcms.2024.01.007_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.joms.2015.08.017","article-title":"Evaluation of bone healing after osteotomies prepared with Er:YAG laser in contact and noncontact modes and piezosurgery--an animal study","volume":"74","author":"Gabri\u0107","year":"2016","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"3","key":"10.1016\/j.jcms.2024.01.007_bib27","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1093\/ejcts\/ezs357","article-title":"Sutures enriched with adipose-derived stem cells decrease the local acute inflammation after tracheal anastomosis in a murine model\u2020","volume":"42","author":"Georgiev-Hristov","year":"2012","journal-title":"Eur. J. Cardio. Thorac. Surg."},{"issue":"5","key":"10.1016\/j.jcms.2024.01.007_bib28","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.oooo.2018.06.007","article-title":"Can platelet-rich fibrin improve healing after surgical treatment of medication-related osteonecrosis of the jaw? A pilot study","volume":"126","author":"Giudice","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.jcms.2024.01.007_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/1479-5876-11-271","article-title":"IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand","volume":"11","author":"Guerra-Men\u00e9ndez","year":"2013","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.jcms.2024.01.007_bib31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"issue":"8","key":"10.1016\/j.jcms.2024.01.007_bib32","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s00198-017-4063-7","article-title":"A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?","volume":"28","author":"Hasegawa","year":"2017","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.jcms.2024.01.007_bib33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5507\/bp.2018.081","article-title":"Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents","volume":"164","author":"Hauer","year":"2020","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"1","key":"10.1016\/j.jcms.2024.01.007_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41368-020-00093-2","article-title":"Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw","volume":"12","author":"He","year":"2020","journal-title":"Int. J. Oral Sci."},{"issue":"1","key":"10.1016\/j.jcms.2024.01.007_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.jcms.2024.01.007_bib36","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.bjoms.2014.07.256","article-title":"Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study","volume":"52","author":"Kim","year":"2014","journal-title":"Br. J. Oral Maxillofac. Surg."},{"issue":"4","key":"10.1016\/j.jcms.2024.01.007_bib37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.oooo.2018.11.012","article-title":"Medication-related osteonecrosis of the jaw unrelated to bisphosphonates and denosumab-a review","volume":"127","author":"King","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"9","key":"10.1016\/j.jcms.2024.01.007_bib38","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1007\/s00520-016-3139-9","article-title":"Bisphosphonate-related osteonecrosis of the jaw: a review of the potential efficacy of low-level laser therapy","volume":"24","author":"Latifyan","year":"2016","journal-title":"Support. Care Cancer"},{"issue":"3","key":"10.1016\/j.jcms.2024.01.007_bib39","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00198-013-2575-3","article-title":"Risk of osteonecrosis in patients taking bisphosphonates for prevention of osteoporosis: a systematic review and meta-analysis","volume":"25","author":"Lee","year":"2014","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.jcms.2024.01.007_bib40","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00784-019-02934-9","article-title":"PRF improves wound healing and postoperative discomfort after harvesting subepithelial connective tissue graft from palate: a randomized controlled trial","volume":"24","author":"Lektemur Alpan","year":"2020","journal-title":"Clin Oral Investig"},{"issue":"2","key":"10.1016\/j.jcms.2024.01.007_bib41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","article-title":"Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure","volume":"68","author":"Lo","year":"2010","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jcms.2024.01.007_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/298945","article-title":"Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: personal experience and review of the literature","author":"Longo","year":"2014","journal-title":"Int J Dent"},{"issue":"10","key":"10.1016\/j.jcms.2024.01.007_bib43","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.3390\/ma13102282","article-title":"Evaluation of different autologous platelet concentrate biomaterials: morphological and biological comparisons and considerations","volume":"13","author":"Marchetti","year":"2020","journal-title":"Materials"},{"issue":"1","key":"10.1016\/j.jcms.2024.01.007_bib44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.oraloncology.2011.08.010","article-title":"Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study","volume":"48","author":"Martins","year":"2012","journal-title":"Oral Oncol."},{"issue":"9","key":"10.1016\/j.jcms.2024.01.007_bib45","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"2","key":"10.1016\/j.jcms.2024.01.007_bib46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/scd.12023","article-title":"Bisphosphonate-related osteonecrosis of the jaws: analysis of a case series at a dental school","volume":"34","author":"Mathias Duarte","year":"2014","journal-title":"Spec Care Dentist"},{"key":"10.1016\/j.jcms.2024.01.007_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3982540","article-title":"Conservative surgical treatment of bisphosphonate-related osteonecrosis of the jaw with Er,Cr:YSGG laser and platelet-rich plasma: a longitudinal study","author":"Mauceri","year":"2018","journal-title":"BioMed Res. Int."},{"issue":"4","key":"10.1016\/j.jcms.2024.01.007_bib48","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/jcb.20462","article-title":"Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation","volume":"95","author":"Mayer","year":"2005","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.jcms.2024.01.007_bib49","doi-asserted-by":"crossref","first-page":"92","DOI":"10.15171\/jlms.2018.19","article-title":"Combined approach to treat medication-related osteonecrosis of the jaws","volume":"9","author":"Merigo","year":"2018","journal-title":"J Lasers Med Sci"},{"key":"10.1016\/j.jcms.2024.01.007_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/4948139","article-title":"The role of platelet-rich fibrin (PRF) in the prevention of medication-related osteonecrosis of the jaw (MRONJ)","volume":"2021","author":"Miranda","year":"2021","journal-title":"BioMed Res. Int."},{"issue":"9","key":"10.1016\/j.jcms.2024.01.007_bib51","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.oraloncology.2012.03.009","article-title":"Tooth extraction in patients on zoledronic acid therapy","volume":"48","author":"Mozzati","year":"2012","journal-title":"Oral Oncol."},{"issue":"5","key":"10.1016\/j.jcms.2024.01.007_bib52","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.oraloncology.2011.12.004","article-title":"Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases","volume":"48","author":"Mozzati","year":"2012","journal-title":"Oral Oncol."},{"issue":"4","key":"10.1016\/j.jcms.2024.01.007_bib53","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4103\/0972-0707.114344","article-title":"Role of Platelet rich fibrin in wound healing: a critical review","volume":"16","author":"Naik","year":"2013","journal-title":"J. Conserv. Dent."},{"issue":"3","key":"10.1016\/j.jcms.2024.01.007_bib54","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10103-017-2400-x","article-title":"Laser for bone healing after oral surgery: systematic review","volume":"33","author":"Noba","year":"2018","journal-title":"Lasers Med Sci"},{"issue":"10","key":"10.1016\/j.jcms.2024.01.007_bib55","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.ijom.2016.04.010","article-title":"Surgical treatment of osteonecrosis of the jaw with the use of platelet-rich fibrin: a prospective study of 15 patients","volume":"45","author":"N\u00f8rholt","year":"2016","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"2","key":"10.1016\/j.jcms.2024.01.007_bib56","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.oooo.2021.05.013","article-title":"Autologous platelet concentrates in oral surgery: protocols, properties, and clinical applications","volume":"133","author":"O'Sullivan","year":"2022","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2","key":"10.1016\/j.jcms.2024.01.007_bib57","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.oooo.2021.06.003","article-title":"Tooth extractions in patients with cancer receiving high-dose antiresorptive medication: a randomized clinical feasibility trial of drug holiday versus drug continuation","volume":"133","author":"Ottesen","year":"2022","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"},{"issue":"11","key":"10.1016\/j.jcms.2024.01.007_bib58","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/jbmr.4119","article-title":"A drug holiday reduces the frequency and severity of medication-related osteonecrosis of the jaw in a minipig model","volume":"35","author":"Otto","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.jcms.2024.01.007_bib59","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1186\/s12903-021-01965-7","article-title":"Promising results of surgical management of advanced medication related osteonecrosis of the jaws using adjunctive leukocyte and platelet rich fibrin","volume":"21","author":"\u00d6zalp","year":"2021","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.jcms.2024.01.007_bib60","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jclinepi.2021.02.003","article-title":"Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement","volume":"134","author":"Page","year":"2021","journal-title":"J. Clin. Epidemiol."},{"issue":"3","key":"10.1016\/j.jcms.2024.01.007_bib61","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10006-022-01094-7","article-title":"Efficacy of fibrin-rich platelets and leukocytes (L-PRF) in tissue repair in surgical oral procedures in patients using zoledronic acid-case-control study","volume":"27","author":"Parise","year":"2023","journal-title":"Oral Maxillofac. Surg."},{"issue":"4","key":"10.1016\/j.jcms.2024.01.007_bib62","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jcms.2020.02.006","volume":"48","author":"Poxleitner","year":"2020","journal-title":"J. Cranio-Maxillo-Fac. Surg."},{"issue":"2","key":"10.1016\/j.jcms.2024.01.007_bib63","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jcms.2014.11.014","article-title":"Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ)","volume":"43","author":"Ristow","year":"2015","journal-title":"J. Cranio-Maxillo-Fac. Surg."},{"issue":"12 Suppl","key":"10.1016\/j.jcms.2024.01.007_bib64","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.jcms.2024.01.007_bib65","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/pho.2010.2835","article-title":"Observation of pain control in patients with bisphosphonate-induced osteonecrosis using low level laser therapy: preliminary results","volume":"29","author":"Romeo","year":"2011","journal-title":"Photomed Laser Surg"},{"issue":"10","key":"10.1016\/j.jcms.2024.01.007_bib66","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"5","key":"10.1016\/j.jcms.2024.01.007_bib67","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American association of oral and maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"1","key":"10.1016\/j.jcms.2024.01.007_bib68","first-page":"23","article-title":"Autologous platelet concentrates in treatment of medication related osteonecrosis of the jaw","volume":"22","author":"Rusilas","year":"2020","journal-title":"Stomatologija"},{"issue":"4","key":"10.1016\/j.jcms.2024.01.007_bib69","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bjorl.2021.04.004","article-title":"Combined approach to treatment of advanced stages of medication-related osteonecrosis of the jaw patients","volume":"88","author":"\u015eahin","year":"2022","journal-title":"Braz J Otorhinolaryngol"},{"issue":"6","key":"10.1016\/j.jcms.2024.01.007_bib70","doi-asserted-by":"crossref","first-page":"e684","DOI":"10.4317\/medoral.24007","article-title":"Medication related osteonecrosis of the jaws (MRONJ): factors related to recurrence after treatment with surgery and platelet rich plasma (PRP) placement","volume":"26","author":"S\u00e1nchez-Gallego Albertos","year":"2021","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"issue":"8","key":"10.1016\/j.jcms.2024.01.007_bib71","first-page":"2893","article-title":"Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients","volume":"9","author":"Santini","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jcms.2024.01.007_bib72","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1472-6947-7-16","article-title":"Utilization of the PICO framework to improve searching PubMed for clinical questions","volume":"7","author":"Schardt","year":"2007","journal-title":"BMC Med Inform Decis Mak"},{"issue":"7","key":"10.1016\/j.jcms.2024.01.007_bib73","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1073\/pnas.93.7.3068","article-title":"Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate","volume":"93","author":"Schmidt","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.jcms.2024.01.007_bib74","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.joms.2010.07.026","article-title":"Initial experience on the outcome of teeth extractions in intravenous bisphosphonate-treated patients: a cautionary report","volume":"69","author":"Scoletta","year":"2011","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"6","key":"10.1016\/j.jcms.2024.01.007_bib75","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.joms.2013.01.006","article-title":"Tooth extractions in intravenous bisphosphonate-treated patients: a refined protocol","volume":"71","author":"Scoletta","year":"2013","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jcms.2024.01.007_bib76","unstructured":"Scottish Dental Clinical Effectiveness Program Guidelines (SDCEP), 2017. Oral Health Management of Patients Prescribed at Risk of Medication-Related Osteonecrosis of the Jaw. Retrieved https:\/\/www.sdcep.org.uk\/media\/m0ko0gng\/sdcep-oral-health-management-of-patients-at-risk-of-mronj-guidance-full.pdf. (Accessed 27 May 2023)."},{"issue":"1","key":"10.1016\/j.jcms.2024.01.007_bib77","doi-asserted-by":"crossref","first-page":"8310","DOI":"10.1038\/s41598-019-43798-z","article-title":"Positive impact of Platelet-rich plasma and Platelet-rich fibrin on viability, migration and proliferation of osteoblasts and fibroblasts treated with zoledronic acid","volume":"9","author":"Steller","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jcms.2024.01.007_bib78","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"Bmj"},{"key":"10.1016\/j.jcms.2024.01.007_bib79","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"issue":"5","key":"10.1016\/j.jcms.2024.01.007_bib80","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.joms.2019.12.008","article-title":"The effect of platelet-rich fibrin membrane in surgical therapy of medication-related osteonecrosis of the jaw","volume":"78","author":"Szentpeteri","year":"2020","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"11","key":"10.1016\/j.jcms.2024.01.007_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9113505","article-title":"Management of medication-related osteonecrosis of the jaw (MRONJ) using leukocyte- and platelet-rich fibrin (L-PRF) and photobiomodulation: a retrospective study","volume":"9","author":"Tenore","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jcms.2024.01.007_bib91","unstructured":"The jamovi project (2020). jamovi. (Version 1.2) [Computer Software]. Retrieved from https:\/\/www.jamovi.org. --> version 1.6."},{"issue":"1","key":"10.1016\/j.jcms.2024.01.007_bib82","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41598-018-37063-y","article-title":"Application of autologous platelet-rich plasma on tooth extraction site prevents occurrence of medication-related osteonecrosis of the jaws in rats","volume":"9","author":"Toro","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jcms.2024.01.007_bib83","series-title":"Medication-related Osteonecrosis of the Jaw: Guidance for the Oncology Multidisciplinary Team","year":"2019"},{"issue":"4","key":"10.1016\/j.jcms.2024.01.007_bib84","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/SCS.0000000000005475","article-title":"Medication-related osteonecrosis of the jaw: the use of leukocyte-platelet-rich fibrin as an adjunct in the treatment","volume":"30","author":"Valente","year":"2019","journal-title":"J. Craniofac. Surg."},{"issue":"3","key":"10.1016\/j.jcms.2024.01.007_bib85","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0714.2011.01091.x","article-title":"Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients","volume":"41","author":"Vescovi","year":"2012","journal-title":"J. Oral Pathol. Med."},{"issue":"2","key":"10.1016\/j.jcms.2024.01.007_bib86","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1601-0825.2010.01720.x","article-title":"Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro","volume":"17","author":"Walter","year":"2011","journal-title":"Oral Dis."},{"issue":"6","key":"10.1016\/j.jcms.2024.01.007_bib87","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s10103-016-1929-4","article-title":"Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): a systematic review","volume":"31","author":"Weber","year":"2016","journal-title":"Lasers Med Sci"},{"issue":"3","key":"10.1016\/j.jcms.2024.01.007_bib88","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/SCS.0000000000009161","article-title":"Use of leukocyte-rich and platelet-rich fibrin (L-PRF) adjunct to surgical debridement in the treatment of stage 2 and 3 medication-related osteonecrosis of the jaw","volume":"34","author":"Yalcin-\u00dclker","year":"2023","journal-title":"J. Craniofac. Surg."},{"issue":"8","key":"10.1016\/j.jcms.2024.01.007_bib89","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1007\/s00784-018-2743-0","article-title":"Treatment outcomes and prognostic factors of medication-related osteonecrosis of the jaw: a case- and literature-based review","volume":"23","author":"Yamada","year":"2019","journal-title":"Clin Oral Investig"},{"issue":"3","key":"10.1016\/j.jcms.2024.01.007_bib90","doi-asserted-by":"crossref","first-page":"322","DOI":"10.5507\/bp.2020.023","article-title":"The use of platelet-rich fibrin in the surgical treatment of medication-related osteonecrosis of the jaw: 40 patients prospective study","volume":"165","author":"Zelinka","year":"2021","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"}],"container-title":["Journal of Cranio-Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518224000192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518224000192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T03:38:49Z","timestamp":1718249929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010518224000192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1010518224000192"],"URL":"https:\/\/doi.org\/10.1016\/j.jcms.2024.01.007","relation":{},"ISSN":["1010-5182"],"issn-type":[{"value":"1010-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effectiveness of autologous platelet concentrates in prevention and treatment of medication-related osteonecrosis of the jaws: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Cranio-Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcms.2024.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd on behalf of European Association for Cranio-Maxillo-Facial Surgery.","name":"copyright","label":"Copyright"}]}}